沃森生物 (300142.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(沃森生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 707,997,626.68833,594,992.68599,753,563.65955,727,961.82990,373,049.551,334,403,950.88833,267,364.92
 营业收入(元) 707,997,626.68833,594,992.68599,753,563.65955,727,961.82990,373,049.551,334,403,950.88833,267,364.92
二、营业总成本(元) 577,375,878.63716,505,825.06462,149,769.99831,344,933.08794,723,944.18864,604,890.49661,539,530.54
 营业成本(元) 153,896,036.63173,209,426.80113,518,843.35146,292,561.52178,696,928.82147,719,533.02124,847,130.69
 研发费用(元) 144,142,872.05199,941,914.5587,020,581.52202,982,966.42208,256,429.32186,277,709.21178,908,157.97
 营业税金及附加(元) 4,394,292.345,170,338.584,173,429.236,653,213.875,660,239.178,093,725.0511,618,775.14
 销售费用(元) 180,482,831.96289,762,269.28210,455,707.93376,223,111.86360,305,936.91478,012,092.75305,034,393.98
 管理费用(元) 96,744,710.4761,382,793.1661,785,575.99116,997,268.9659,731,085.7562,661,956.8858,233,428.59
 财务费用(元) -2,284,864.82-12,960,917.31-14,804,368.03-17,804,189.55-17,926,675.79-18,160,126.42-17,102,355.83
  其中:利息费用(元) 1,324,394.272,969,576.643,381,948.432,192,065.991,032,799.681,444,888.601,279,052.66
  其中:利息收入(元) 13,107,129.7514,796,490.4918,310,787.1621,573,697.0816,400,733.5318,590,924.3817,667,344.54
 资产减值损失(元) -30,873,775.33-59,730,537.26-7,606,338.91-150,068,335.47-8,980,156.563,415,488.18-7,007,202.59
 信用减值损失(元) -17,431,127.8068,584,559.23-9,893,290.24-21,436,098.62-6,407,197.66-60,017,871.41-658,312.13
三、其他经营收益
 加:公允价值变动收益(元) 8,319,700.00-17,191,900.00-84,817,900.00-167,361,200.00-49,736,000.00-16,460,000.00-1,192,900.00
 加:投资收益(元) 1,242,501.043,567,601.9486,840.07819,848.32-33,740.396,596,063.03-267,698.82
  其中:对联营企业和合营企业的投资收益(元) 73,508.31-85,532.5586,840.07819,848.32-33,740.39-188,329.59-215,687.63
 资产处置收益(元) -2,943.09---252,867.99-747,078.17-172,214.11
 其他收益(元) 5,790,160.2916,556,815.3724,276,049.9148,570,127.1817,511,241.5614,244,123.5051,704,673.30
四、营业利润(元) 97,666,263.16128,767,548.6959,649,154.49-165,345,497.84147,256,174.15417,576,863.69214,478,608.25
 加:营业外收入(元) 19.15126,923,987.57101.881,871.9920,001.68864,334.1948,847.78
 减:营业外支出(元) 1,570,335.3735,251,523.722,396,025.769,900,943.061,078,879.491,149,373.363,795,520.68
五、利润总额(元) 96,095,946.94220,440,012.5457,253,230.61-175,244,568.91146,197,296.34417,291,824.52210,731,935.35
 减:所得税费用(元) 2,971,189.091,236,112.4018,941,003.7010,659,734.9911,517,027.8353,046,691.3712,427,935.12
六、净利润(元) 93,124,757.85219,203,900.1438,312,226.91-185,904,303.90134,680,268.51364,245,133.15198,304,000.23
(一)按经营持续性分类
  持续经营净利润(元) 93,124,757.85219,203,900.1438,312,226.91-185,904,303.90134,680,268.51364,245,133.15198,304,000.23
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 85,798,163.00156,432,922.6014,127,534.12-133,986,245.2998,136,640.53283,248,921.27171,990,894.69
  少数股东损益(元) 7,326,594.8562,770,977.5424,184,692.79-51,918,058.6136,543,627.9880,996,211.8826,313,105.54
 扣除非经常性损益后的净利润(元) 77,964,589.5061,956,615.0184,033,848.2115,990,118.95135,818,292.29287,591,114.63134,185,505.00
七、每股收益
 一、基本每股收益(元) 0.050.100.01-0.080.060.180.11
 二、稀释每股收益(元) 0.050.100.01-0.080.060.180.11
九、综合收益总额(元) 93,124,757.85219,203,900.1438,312,226.91-185,904,303.90134,680,268.51364,245,133.15198,304,000.23
 归属于母公司所有者的综合收益总额(元) 85,798,163.00156,432,922.6014,127,534.12-133,986,245.2998,136,640.53283,248,921.27171,990,894.69
 归属于少数股东的综合收益总额(元) 7,326,594.8562,770,977.5424,184,692.79-51,918,058.6136,543,627.9880,996,211.8826,313,105.54
公告日期 2024-10-262024-08-282024-04-252024-03-302023-10-262023-08-262023-04-25
审计意见(境内) 标准无保留意见

前瞻产业研究院